Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gather information about the steady-state plasma
concentrations of aripiprazole, olanzapine, quetiapine and their relevant metabolites, at
various dose levels and at different time points after dosing. In addition, comparison of
capillary drug concentrations vs. venous drug concentrations will be performed for
aripiprazole, olanzapine, paliperidone, quetiapine, risperidone and their relevant
metabolites.